Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...

Residents including parents of children who have received care for two conditions — asthma and chronic obstructive pulmonary disease — have been asked to assist in guiding the island’s healthcare ...

Obama officials omitted Russian intel on Hillary Clinton’s alleged health problems while saying Russian President Vladimir Putin aimed to help President Donald Trump, according to newly declassified ...

The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...

Astegolimab from Roche's Genentech fails phase 3 COPD trial, reflecting challenges in monoclonal antibody treatment for the ...

DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living with chronic lung diseases such as bronchiectasis, cystic fibrosis and chronic ...

The fate of IL-33-targeting astegolimab will be determined by talks with regulators, after Roche AG’s Genentech unit rolled out mixed results from a pair of studies testing the compound vs. placebo on ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 ...

Digital inhalers can detect significant changes in physiologic and inhaler use metrics in the 14 days before COPD exacerbations.

COPD study links increased alveolar macrophage carbon to worse lung function, inflammation, and altered cell phenotype.